UK markets closed
  • FTSE 100

    5,577.27
    -4.48 (-0.08%)
     
  • FTSE 250

    17,214.38
    +36.70 (+0.21%)
     
  • AIM

    948.60
    -0.70 (-0.07%)
     
  • GBP/EUR

    1.1104
    +0.0040 (+0.36%)
     
  • GBP/USD

    1.2953
    +0.0030 (+0.23%)
     
  • BTC-GBP

    10,653.80
    +58.50 (+0.55%)
     
  • CMC Crypto 200

    265.42
    +1.78 (+0.68%)
     
  • S&P 500

    3,269.96
    -40.15 (-1.21%)
     
  • DOW

    26,501.60
    -157.51 (-0.59%)
     
  • CRUDE OIL

    35.72
    -0.45 (-1.24%)
     
  • GOLD FUTURES

    1,878.80
    +10.80 (+0.58%)
     
  • NIKKEI 225

    22,977.13
    -354.81 (-1.52%)
     
  • HANG SENG

    24,107.42
    -479.18 (-1.95%)
     
  • DAX

    11,556.48
    -41.59 (-0.36%)
     
  • CAC 40

    4,594.24
    +24.57 (+0.54%)
     

Global Rheumatoid Arthritis Diagnosis Tests Industry (2020 to 2027) - Market Trajectory & Analytics

Research and Markets
·2-min read

Dublin, Sept. 24, 2020 (GLOBE NEWSWIRE) -- The "Rheumatoid Arthritis Diagnosis Tests - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.

The publisher brings years of research experience to the 8th edition of this report. The 276-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.

Global Rheumatoid Arthritis Diagnosis Tests Market to Reach $852.8 Million by 2027

Amid the COVID-19 crisis, the global market for Rheumatoid Arthritis Diagnosis Tests estimated at US$599.9 Million in the year 2020, is projected to reach a revised size of US$852.8 Million by 2027, growing at a CAGR of 5.2% over the period 2020-2027.

Serology Tests, one of the segments analyzed in the report, is projected to record 5.5% CAGR and reach US$630.2 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Monitoring RA Treatment Efficiency Tests segment is readjusted to a revised 4.3% CAGR for the next 7-year period.

The U.S. Market is Estimated at $162.5 Million, While China is Forecast to Grow at 7.8% CAGR

The Rheumatoid Arthritis Diagnosis Tests market in the U.S. is estimated at US$162.5 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$176.8 Million by the year 2027 trailing a CAGR of 7.9% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 2.8% and 4.6% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 3.2% CAGR.

Competitors identified in this market include, among others:

  • Abbott Laboratories

  • Antibodies Inc.

  • Aviva Systems Biology Corporation

  • Beckman Coulter, Inc.

  • Bio-Rad laboratories Inc.

  • Euro Diagnostica AB

  • F. Hoffmann-La Roche AG

  • Qiagen NV

  • Siemens Healthineers

  • Thermo Fisher Scientific, Inc.

Key Topics Covered:

I. INTRODUCTION, METHODOLOGY & REPORT SCOPE

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

  • Global Competitor Market Shares

  • Rheumatoid Arthritis Diagnosis Tests Competitor Market Share Scenario Worldwide (in %): 2019 & 2025

  • Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE

III. MARKET ANALYSIS

IV. COMPETITION

  • Total Companies Profiled: 42

For more information about this report visit https://www.researchandmarkets.com/r/w32995

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900